Importance Phosphorylated tau (p-tau) is a specific blood biomarker for Alzheimer disease (AD)
pathology, with p-tau217 considered to have the most utility. However, availability of p-…

Recent longitudinal PET imaging studies have established methods to estimate the age at
which amyloid becomes abnormal at the level of the individual. Here we recontextualized …

… Plasma Aβ42/40, GFAP and NfL were quantified using the commercial Neurology 4-plex E
kit (#103670, Quanterix). Plasma pTau231 and pTau181 were analysed using in-house Simoa …

Neurovascular 4D-Flow MRI enables non-invasive evaluation of cerebral hemodynamics
including measures of cerebral blood flow (CBF), vessel pulsatility index (PI), and cerebral …

Fetal embryo, head, and brain tissue from different gestational age were analyzed for retinol
content, nuclear retinoic acid receptor and cytosolic retinoic acid binding protein levels after …

Purpose: To determine the prevalence of cigarette, alcohol and other drug use and associated
factors of use among predominantly Caucasian small-city pregnant adolescents, a little-…

INTRODUCTION Published norms are typically cross‐sectional and often are not sensitive
to preclinical cognitive changes due to dementia. We developed and validated …

Background In the last 5 years, immunoassays for the quantification of phosphorylated tau (p‐tau)
in blood have proven to accurately identify Alzheimer’s disease (AD) pathology with …

Background The timing of AD biomarker positivity may be important for defining optimal anti‐amyloid
therapy windows for secondary prevention. This work characterizes the AD …

Background Exposome social determinants of health (SDoH), such as neighborhood
disadvantage, have shown associations with accelerated cognitive decline, brain volume loss, and …